Tags

Type your tag names separated by a space and hit enter

[Current pharmacotherapy of overactive bladder in neurological patients].
Zh Nevrol Psikhiatr Im S S Korsakova. 2014; 114(12):152-160.ZN

Abstract

The literature data on the urgent neurological problem - overactive bladder (OAB) are summarized. The OAB prevalence, current conceptions on the physiology and pathophysiology of urination and pathogenetic mechanisms of OAB development are presented. Main groups of pharmacological agents used in OAB treatment are described. Special attention is drawn to rationale of using anticholinergic (antimuscarinic) drugs. The authors present the results of their own comparative analysis on the efficacy and tolerability of these drugs in treatment of patients with cerebral vascular diseases including the use of solifenacin succinate (VESIcare).

Authors+Show Affiliations

FGBU 'Nauchnyĭ tsentr nevrologii' RAMN, Moskva; Nauchno-issledovatel'skiĭ institut uronefrologii i reproduktivnogo zdorov'ia cheloveka, Moskva.Nauchno-issledovatel'skiĭ institut uronefrologii i reproduktivnogo zdorov'ia cheloveka, Moskva; GBOU VPO 'Pervyĭ moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova', Moskva.FGBU 'Nauchnyĭ tsentr nevrologii' RAMN, Moskva.FGBU 'Nauchnyĭ tsentr nevrologii' RAMN, Moskva.FGBU 'Nauchnyĭ tsentr nevrologii' RAMN, Moskva.FGBU 'Nauchnyĭ tsentr nevrologii' RAMN, Moskva.

Pub Type(s)

English Abstract
Journal Article
Review

Language

rus

PubMed ID

25741549

Citation

Shvarts, P G., et al. "[Current Pharmacotherapy of Overactive Bladder in Neurological Patients]." Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova, vol. 114, no. 12, 2014, pp. 152-160.
Shvarts PG, Vinarov AZ, Kadykov AS, et al. [Current pharmacotherapy of overactive bladder in neurological patients]. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(12):152-160.
Shvarts, P. G., Vinarov, A. Z., Kadykov, A. S., Borodulina, I. V., Popov, S. V., & Kravchenko, M. A. (2014). [Current pharmacotherapy of overactive bladder in neurological patients]. Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova, 114(12), 152-160. https://doi.org/10.17116/jnevro2014114121152-160
Shvarts PG, et al. [Current Pharmacotherapy of Overactive Bladder in Neurological Patients]. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(12):152-160. PubMed PMID: 25741549.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Current pharmacotherapy of overactive bladder in neurological patients]. AU - Shvarts,P G, AU - Vinarov,A Z, AU - Kadykov,A S, AU - Borodulina,I V, AU - Popov,S V, AU - Kravchenko,M A, PY - 2015/3/6/entrez PY - 2014/1/1/pubmed PY - 2015/5/6/medline SP - 152 EP - 160 JF - Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova JO - Zh Nevrol Psikhiatr Im S S Korsakova VL - 114 IS - 12 N2 - The literature data on the urgent neurological problem - overactive bladder (OAB) are summarized. The OAB prevalence, current conceptions on the physiology and pathophysiology of urination and pathogenetic mechanisms of OAB development are presented. Main groups of pharmacological agents used in OAB treatment are described. Special attention is drawn to rationale of using anticholinergic (antimuscarinic) drugs. The authors present the results of their own comparative analysis on the efficacy and tolerability of these drugs in treatment of patients with cerebral vascular diseases including the use of solifenacin succinate (VESIcare). SN - 1997-7298 UR - https://www.unboundmedicine.com/medline/citation/25741549/[Current_pharmacotherapy_of_overactive_bladder_in_neurological_patients]_ L2 - https://medlineplus.gov/overactivebladder.html DB - PRIME DP - Unbound Medicine ER -